Hospital de Santa Clara (Dr Ortiz), Bogotá, Colombia.
Chest. 2010 Jun;137(6):1265-77. doi: 10.1378/chest.09-2131. Epub 2009 Dec 18.
Few data are available regarding the benefits of one mode over another for ventilatory support. We set out to compare clinical outcomes of patients receiving synchronized intermittent mandatory ventilation with pressure support (SIMV-PS) compared with assist-control (A/C) ventilation as their primary mode of ventilatory support.
This was a secondary analysis of an observational study conducted in 349 ICUs from 23 countries. A propensity score stratified analysis was used to compare 350 patients ventilated with SIMV-PS with 1,228 patients ventilated with A/C ventilation. The primary outcome was in-hospital mortality.
In a logistic regression model, patients were more likely to receive SIMV-PS if they were from North America, had lower severity of illness, or were ventilated postoperatively or for trauma. SIMV-PS was less likely to be selected if patients were ventilated because of asthma or coma, or if they developed complications such as sepsis or cardiovascular failure during mechanical ventilation. In the stratified analysis according to propensity score, we did not find significant differences in the in-hospital mortality. After adjustment for propensity score, overall effect of SIMV-PS on in-hospital mortality was not significant (odds ratio, 1.04; 95% CI, 0.77-1.42; P = .78).
In our cohort of ventilated patients, ventilation with SIMV-PS compared with A/C did not offer any advantage in terms of clinical outcomes, despite treatment-allocation bias that would have favored SIMV-PS.
关于通气支持中一种模式优于另一种模式的益处的数据很少。我们旨在比较接受同步间歇强制通气加压力支持(SIMV-PS)与辅助控制(A/C)通气作为主要通气支持模式的患者的临床结局。
这是一项在 23 个国家的 349 个 ICU 进行的观察性研究的二次分析。采用倾向评分分层分析比较了 350 例接受 SIMV-PS 通气的患者和 1228 例接受 A/C 通气的患者。主要结局是院内死亡率。
在逻辑回归模型中,如果患者来自北美、疾病严重程度较低、术后或因创伤而接受通气,则更有可能接受 SIMV-PS。如果患者因哮喘或昏迷而接受通气,或在机械通气期间出现败血症或心血管衰竭等并发症,则不太可能选择 SIMV-PS。根据倾向评分进行分层分析,我们没有发现院内死亡率存在显著差异。在调整倾向评分后,SIMV-PS 对院内死亡率的总体影响不显著(优势比,1.04;95%CI,0.77-1.42;P=0.78)。
在我们的通气患者队列中,与 A/C 相比,SIMV-PS 通气在临床结局方面没有优势,尽管存在治疗分配偏倚,这可能有利于 SIMV-PS。